Search Results

There are 10377 results for: content related to: Generalized pustular psoriasis triggered by infliximab in two patients with C rohn's disease

  1. Clinical implications of variations in anti-infliximab antibody levels in patients with inflammatory bowel disease

    Inflammatory Bowel Diseases

    Volume 18, Issue 12, December 2012, Pages: 2209–2217, Casper Steenholdt, Magid Al-khalaf, Jørn Brynskov, Klaus Bendtzen, Ole Ø. Thomsen and Mark A. Ainsworth

    Version of Record online : 16 FEB 2012, DOI: 10.1002/ibd.22910

  2. Monitoring functional serum antitumor necrosis factor antibody level in Crohn's disease patients who maintained and those who lost response to anti-TNF

    Inflammatory Bowel Diseases

    Volume 16, Issue 11, November 2010, Pages: 1898–1904, Akihiro Yamada, Koji Sono, Nobuo Hosoe, Nobuo Takada and Yasuo Suzuki

    Version of Record online : 22 MAR 2010, DOI: 10.1002/ibd.21259

  3. Safety profiles and efficacy of infliximab therapy in Japanese patients with plaque psoriasis with or without psoriatic arthritis, pustular psoriasis or psoriatic erythroderma: Results from the prospective post-marketing surveillance

    The Journal of Dermatology

    Volume 43, Issue 7, July 2016, Pages: 767–778, Hideshi Torii, Tadashi Terui, Miyuki Matsukawa, Kazumi Takesaki, Mamitaro Ohtsuki, Hidemi Nakagawa and The Japanese Dermatological Association (JDA) PMS committee

    Version of Record online : 24 DEC 2015, DOI: 10.1111/1346-8138.13214

  4. You have free access to this content
    Pre-existing IgG antibodies cross-reacting with the Fab region of infliximab predict efficacy and safety of infliximab therapy in inflammatory bowel disease

    Alimentary Pharmacology & Therapeutics

    Volume 37, Issue 12, June 2013, Pages: 1172–1183, C. Steenholdt, Y. Palarasah, K. Bendtzen, A. Teisner, J. Brynskov, B. Teisner and C. H. Nielsen

    Version of Record online : 7 MAY 2013, DOI: 10.1111/apt.12330

  5. You have free access to this content
    Protection from articular damage by passive or active anti-tumour necrosis factor (TNF)-α immunotherapy in human TNF-α transgenic mice depends on anti-TNF-α antibody levels

    Clinical & Experimental Immunology

    Volume 172, Issue 1, April 2013, Pages: 54–62, L. Semerano, J. Biton, L. Delavallée, E. Duvallet, E. Assier, N. Bessis, E. Bernier, O. Dhellin, G. Grouard-Vogel and M.-C. Boissier

    Version of Record online : 10 MAR 2013, DOI: 10.1111/cei.12040

  6. Clinical utility of antihuman lambda chain-based enzyme-linked immunosorbent assay (ELISA) versus double antigen ELISA for the detection of anti-infliximab antibodies

    Inflammatory Bowel Diseases

    Volume 18, Issue 9, September 2012, Pages: 1628–1633, Uri Kopylov, Yoav Mazor, Miri Yavzori, Ella Fudim, Lior Katz, Daniel Coscas, Orit Picard, Yehuda Chowers, Rami Eliakim and Shomron Ben-Horin

    Version of Record online : 29 OCT 2011, DOI: 10.1002/ibd.21919

  7. You have free access to this content
    eHealth: individualisation of infliximab treatment and disease course via a self-managed web-based solution in Crohn's disease

    Alimentary Pharmacology & Therapeutics

    Volume 36, Issue 9, November 2012, Pages: 840–849, N. Pedersen, M. Elkjaer, D. Duricova, J. Burisch, C. Dobrzanski, N. N. Andersen, T. Jess, F. Bendtsen, E. Langholz, S. Leotta, T. Knudsen, N. Thorsgaard and P. Munkholm

    Version of Record online : 12 SEP 2012, DOI: 10.1111/apt.12043

  8. You have free access to this content
    Severe infusion reactions to infliximab: aetiology, immunogenicity and risk factors in patients with inflammatory bowel disease

    Alimentary Pharmacology & Therapeutics

    Volume 34, Issue 1, July 2011, Pages: 51–58, C. Steenholdt, M. Svenson, K. Bendtzen, O. Ø. Thomsen, J. Brynskov and M. A. Ainsworth

    Version of Record online : 3 MAY 2011, DOI: 10.1111/j.1365-2036.2011.04682.x

  9. You have free access to this content
    The duration of effect of infliximab maintenance treatment in paediatric Crohn’s disease is limited

    Alimentary Pharmacology & Therapeutics

    Volume 33, Issue 2, January 2011, Pages: 243–250, C. I. De Bie, T. Z. Hummel, A. Kindermann, F. T. M. Kokke, G. M. Damen, C. M. F. Kneepkens, P. F. Van Rheenen, J. J. Schweizer, J. H. Hoekstra, O. F. Norbruis, W. E. Tjon a Ten, A. C. Vreugdenhil, J. M. Deckers-Kocken, C. F. M. Gijsbers, J. C. Escher and L. De Ridder

    Version of Record online : 14 NOV 2010, DOI: 10.1111/j.1365-2036.2010.04507.x

  10. Gastroenterologists' prescribing of infliximab for Crohn's disease: A national survey

    Inflammatory Bowel Diseases

    Volume 15, Issue 10, October 2009, Pages: 1467–1475, Meaghan St. Charles, Sheila R. Weiss Smith, Robert Beardsley, Donald O. Fedder, Olivia Carter-Pokras and Raymond K. Cross

    Version of Record online : 5 MAR 2009, DOI: 10.1002/ibd.20904

  11. You have free access to this content
    Review article: why, when and how to de-escalate therapy in inflammatory bowel diseases

    Alimentary Pharmacology & Therapeutics

    Volume 40, Issue 4, August 2014, Pages: 338–353, B. Pariente and D. Laharie

    Version of Record online : 23 JUN 2014, DOI: 10.1111/apt.12838

  12. The efficacy and safety of either infliximab or adalimumab in 362 patients with anti-TNF-α naïve Crohn's disease

    Alimentary Pharmacology & Therapeutics

    Volume 44, Issue 2, July 2016, Pages: 170–180, N. Narula, S. Kainz, W. Petritsch, T. Haas, T. Feichtenschlager, G. Novacek, A. Eser, H. Vogelsang, W. Reinisch and P. Papay

    Version of Record online : 26 MAY 2016, DOI: 10.1111/apt.13671

  13. Incidence and clinical significance of immunogenicity to infliximab in Crohn's disease: A critical systematic review

    Inflammatory Bowel Diseases

    Volume 15, Issue 8, August 2009, Pages: 1264–1275, Andrea Cassinotti and Simon Travis

    Version of Record online : 23 FEB 2009, DOI: 10.1002/ibd.20899

  14. You have free access to this content
    Detection of infliximab levels and anti-infliximab antibodies: a comparison of three different assays

    Alimentary Pharmacology & Therapeutics

    Volume 36, Issue 8, October 2012, Pages: 765–771, N. Vande Casteele, D. J. Buurman, M. G. G. Sturkenboom, J. H. Kleibeuker, S. Vermeire, T. Rispens, D. van der Kleij, A. Gils and G. Dijkstra

    Version of Record online : 28 AUG 2012, DOI: 10.1111/apt.12030

  15. Efficacy of adalimumab and methotrexate combination therapy on generalized pustular psoriasis patients unresponsive to infliximab monotherapy due to anti-infliximab antibody development

    The Journal of Dermatology

    Volume 42, Issue 1, January 2015, Pages: 94–95, Hiroshi Kawakami, Tatsurou Maeda, Namiko Abe, Yuka Matsumoto, Yoshihiko Mitsuhashi, Ryoji Tsuboi and Yukari Okubo

    Version of Record online : 26 NOV 2014, DOI: 10.1111/1346-8138.12704

  16. Perioperative management of tumor necrosis factor-alpha blocker-treated psoriatic patients: Case reports and review

    The Journal of Dermatology

    Volume 43, Issue 2, February 2016, Pages: 190–193, Hiroshi Kawakami, Yuka Matsumoto, Namiko Abe, Youich Katori, Kousuke Takahashi, Ryoji Tsuboi and Yukari Okubo

    Version of Record online : 8 SEP 2015, DOI: 10.1111/1346-8138.13047

  17. You have free access to this content
    Antitumor necrosis factor treatment for pediatric inflammatory bowel disease

    Inflammatory Bowel Diseases

    Volume 18, Issue 5, May 2012, Pages: 985–1002, Charlotte I. de Bie, Johanna C. Escher and Lissy de Ridder

    Version of Record online : 20 SEP 2011, DOI: 10.1002/ibd.21871

  18. Long-term outcome of treatment with infliximab in pediatric-onset Crohn's disease: A population-based study

    Inflammatory Bowel Diseases

    Volume 17, Issue 10, October 2011, Pages: 2144–2152, Valérie Crombé, Julia Salleron, Guillaume Savoye, Jean-Louis Dupas, Gwénola Vernier-Massouille, Eric Lerebours, Antoine Cortot, Véronique Merle, Francis Vasseur, Dominique Turck, Corinne Gower-Rousseau, Marc Lémann, Jean-Frédéric Colombel and Alain Duhamel

    Version of Record online : 1 FEB 2011, DOI: 10.1002/ibd.21615

  19. You have free access to this content
    Predictors of response to infliximab in paediatric perianal Crohn's disease

    Alimentary Pharmacology & Therapeutics

    Volume 40, Issue 8, October 2014, Pages: 917–929, C. Dupont-Lucas, A. Dabadie, C. Alberti and F. M. Ruemmele, for the GETAID (Groupe d'Etude thérapeutique des Affections Inflammatoires du Tube Digestif) pédiatrique

    Version of Record online : 21 AUG 2014, DOI: 10.1111/apt.12928

  20. You have free access to this content
    IBD Clinical

    Journal of Gastroenterology and Hepatology

    Volume 29, Issue S2, October 2014, Pages: 102–123,

    Version of Record online : 13 OCT 2014, DOI: 10.1111/jgh.12736_6